Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiovascular surgery devices include devices used in cardiovascular surgeries such as coronary artery bypass surgery. Beating heart surgery systems are utilized while performing an off-pump Coronary Artery Bypass Grafting (CABG) procedure. GlobalData uses proprietary data and analytics to provide a comprehensive report on the beating heart surgery systems market in China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the beating heart surgery systems market in China was Beijing Hangtian Kadi Technology R&D Institute followed by Getinge, Jinhwa Medical, Medtronic, Sumitomo Bakelite and Terumo.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Surgeons use special positioners and stabilizers to position and stabilize the part of the heart on which they are operating on. The heart continues to beat during the operation. Surgery on a beating heart helps reduce the risk for complications associated with temporarily stopping the heart during surgery. Positioners guide and hold the heart in a position that provides the best access to the blocked arteries. Stabilizers hold a small area of the heart still while a surgeon works on it.
The beating heart surgery systems market in China can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size beating heart surgery systems in China, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
